Global Skin Biopsy Market Growth (Status and Outlook) 2023-2029

Global Skin Biopsy Market Growth (Status and Outlook) 2023-2029

Skin biopsy is a procedure involving the removal of skin for examination and providing information about any disease or clinical conditions. It is performed to determine the presence of any cancerous cells or any type of skin diseases. Skin cancer, actinic keratosis, dermatitis, psoriasis, and skin infection are various diseases that can be diagnosed through skin biopsy. During the procedure, the sample taken from the affected or diseased part of the skin is placed in formaldehyde solution, the tissue is processed and then examined under the microscope.

LPI (LP Information)' newest research report, the “Skin Biopsy Industry Forecast” looks at past sales and reviews total world Skin Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Skin Biopsy sales for 2023 through 2029. With Skin Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Skin Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Skin Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Skin Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Skin Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Skin Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Skin Biopsy.

The global Skin Biopsy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

America secures a leading position in the market for skin biopsy owing to the rising prevalence of skin diseases and cancer in the U.S. and presence of key market players. According to the American Academy of Dermatology (AAD), skin diseases affects one in every fourth American. The prevalence of skin diseases is also found to be increasing in Canada.

Europe is the second largest market for skin biopsy. Increasing prevalence of skin diseases such as fungal infections, and dermatitis, and increasing demand for technological advanced diagnostic services further drive the market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Skin Biopsy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Shave Biopsy
Excisional Biopsy
Incisional Biopsy

Segmentation by application
Hospital Use
Clinic Use
Research Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific Corporation (US)
COOK Medical (US)
BD (US)
DTR Medical Ltd (U.K)
Devicor Medical Products, Inc.
Leica Biosystems. (US)
Gallini Srl (Italy)
Hologic(US)
Cardinal Health (US)

Please note: The report will take approximately 2 business days to prepare and deliver.